Mike is the UK NSC head of public and professional engagement, information and knowledge. A former journalist, he has worked in screening since 2010.
Anneke helps the UK NSC navigate the complexities of clinical genetics evidence in screening when public expectations about the ability of genetics to predict ill health are running high.
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
The UK NSC is very excited by the news, announced on International Men’s Day, of a major new prostate cancer screening trial backed by £42 million of funding from Prostate Cancer UK and the government.
Please complete a short survey to help us make sure the UK NSC web pages are fit for purpose and meet the needs of all our stakeholders.
The NHS in England will this month start inviting people at lower risk of diabetic retinopathy for diabetic eye screening every 2 years instead of every year.
The UK NSC is consulting on whether providers and commissioners can safely use digital pathology in existing cancer screening programmes, excluding cytology, as an alternative to light microscopy.